Home » Cervicheck Shark Tank India Season 3

Cervicheck Shark Tank India Season 3

by IndiaSuccessStories
0 comment
Cervicheck Shark Tank India Season 3 Got 75 Lakhs Funding in Exchange of 5% Equity by Namita Thapar

Cervicheck Shark Tank India Season 3

Pitch no with company details


Despite the fact that cervical cancer is treatable, many women have lost their lives to the disease as a result of delayed diagnosis and social stigma. In order to provide women with comfort, privacy, and care, Pragmatech Solutions Pvt Ltd developed the CerviCheck self-sampling kit for cervical cancer in order to address this issue.

Founder of Cervicheck

Cervicheck’s founders Anirban Palit and Sayantani Pramanik.

Cervicheck Funding Round

Company Name


Shark Tank India Season


Episode No


Season No





Solution for cervical cancer

Original Ask

75 Lakhs for 1.5% equity


75 Lakhs for 5% equity

Invested By:

Namita Thapar

At the heart of Cervicheck's pitch was a commitment to addressing a pressing public health issue and saving lives. Cervical cancer is a leading cause of cancer-related deaths among women worldwide, and early detection is critical for improving outcomes and reducing mortality rates. By offering a convenient and accessible screening tool, Cervicheck aimed to empower women, particularly those in underserved communities, to prioritize their health and undergo regular screenings for cervical cancer.

The Pitch:

Cervicheck entered the tank with a mission to revolutionize women's healthcare by offering an innovative solution for the early detection of cervical cancer. Their idea was to develop a user-friendly and affordable screening tool that could be easily administered at home, empowering women to take charge of their health and detect potential abnormalities at an early stage. With an original ask of 75 Lakhs for 1.5% equity, Cervicheck sought investment to further develop their technology, conduct clinical trials, and bring their life-saving solution to market.

The Deal:

Impressed by the potential impact of Cervicheck's solution and the importance of addressing women's health issues, Namita Thapar seized the opportunity to support the groundbreaking venture. She offered 75 Lakhs for 5% equity, recognizing the value of Cervicheck's mission and the potential for their solution to save countless lives. With Namita Thapar's investment, Cervicheck was well-positioned to accelerate their development efforts, conduct clinical trials, and pave the way for widespread adoption of their life-saving technology.

Investors Behind Cervicheck

Namita Thapar: With Namita Thapar's backing, Cervicheck was poised to make significant strides in the fight against cervical cancer. The infusion of capital provided by Namita Thapar would enable Cervicheck to advance their research and development efforts, refine their technology, and navigate the regulatory approval process. With Namita Thapar's support and expertise, Cervicheck was on track to make a meaningful impact on women's health and save lives around the world.


Cervicheck's appearance on Shark Tank India Season 3, Episode 29 underscored the importance of innovation and entrepreneurship in addressing critical public health issues. As they continue to develop and refine their life-saving solution, Cervicheck is poised to transform the landscape of women's healthcare and make a tangible difference in the lives of women everywhere. With Namita Thapar's investment and support, Cervicheck is well-equipped to fulfill its mission of combating cervical cancer and promoting early detection for the benefit of women's health globally.

You may also like

Leave a Comment

Indian Success Stories Logo

Indian Success Stories is committed to inspiring the world’s visionary leaders who are driven to make a difference with their ground-breaking concepts, ventures, and viewpoints. Join together with us to match your business with a community that is unstoppable and working to improve everyone’s future.

Edtior's Picks

Latest Articles

Copyright © 2024 Indian Success Stories. All rights reserved.